Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

Tofacitinib is beneficial in treating atopic dermatitis in phase IIa study

Oct. 23, 2015

OPA-15406 shows promise in phase II atopic dermatitis trial

Oct. 22, 2015

Foamix initiates phase II trial of FMX-103 in papulopustular rosacea

Oct. 22, 2015

RXi Pharmaceuticals reports interim data from phase IIa study of RXI-109

Oct. 19, 2015

Izun Pharmaceuticals reports data from phase II trial in diabetic foot ulcers

Oct. 15, 2015

Sebacia completes enrollment in trial of acne treatment

Oct. 13, 2015

Boehringer Ingelheim reports phase II data for BI-655066 in psoriasis

Oct. 9, 2015

Osiris begins phase III trial of OTI-15-01 in chronic diabetic foot wounds

Oct. 8, 2015

BARDA awards contract to Stratatech for StrataGraft skin substitute

Oct. 7, 2015

FDA accepts Sandoz BLA for biosimilar etanercept

Oct. 5, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...